Steven Johnson syndrome (SJS) is a rare life-threatening inflammatory mucocutaneous reaction, counting 1-2 cases per million each year. Among the defined triggers of SJS, drugs are considered the most important. Herein is reported a case of SJS appeared ten days after the administration of the second dose of Astrazeneca COVID-19 vaccine.
Stevens-Johnson syndrome induced by Vaxvetria (AZD1222) COVID-19 vaccine / Aimo C.; Mariotti E.B.; Corra A.; Cipollini E.; Le Rose O.; Serravalle C.; Pimpinelli N.; Caproni M.. - In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. - ISSN 1468-3083. - ELETTRONICO. - 36:(2022), pp. 0-0. [10.1111/jdv.17988]
Stevens-Johnson syndrome induced by Vaxvetria (AZD1222) COVID-19 vaccine
Aimo C.;Mariotti E. B.;Pimpinelli N.;Caproni M.
2022
Abstract
Steven Johnson syndrome (SJS) is a rare life-threatening inflammatory mucocutaneous reaction, counting 1-2 cases per million each year. Among the defined triggers of SJS, drugs are considered the most important. Herein is reported a case of SJS appeared ten days after the administration of the second dose of Astrazeneca COVID-19 vaccine.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Stevens-Johnson syndrome induced by Vaxvetria (AZD1222) COVID-19 vaccine.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
4.36 MB
Formato
Adobe PDF
|
4.36 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
